Acotec (å ēč¾¾) Pre-IPO: Thoughts on Valuation
We provide our forecast and valuation for the company's two key products AcoArt Orchid & Dhalia, as well as AcoArt Tulip & Litos.
305 Views
Shanghai HeartCare (åæē®å»ē) Pre-IPO: Thoughts on Valuation
We forecast the sales of HeartCare's four key products, namely Captor, Intracranial Catheter, LAA Occluder, and embolic coil, and also provide an...
569 Views
ECM Weekly (4th July 2021) - Xpeng, Medbot, Medlive, Brii Bio, CTOS, LinkDoc, Devyani, Manycore
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
684 Views
Acotec (å ēč¾¾) Pre-IPO: Early Mover Advantage in Peripheral DCB
Acotec is early in the peripheral artery drug coated balloon device market with a dominant market share for above-the-knee stenosis. Having said...
474 Views
Pre-IPO Acotec Scientific Holdings - First-Mover Advantage Together with Challenges
This article analyzedĀ Acotec Scientific in terms of itsĀ business, industry characteristics, financial position, and also include the concerns and...
509 Views